MARIMED INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.1M | $3.6M | $1.3M | $88.4K | $904 | $785 | $125.6K |
| Cost of Revenue | $2.2M | $1.4M | $1.6M | $190.2K | $26.3K | $19.9K | $23.0K |
| Gross Profit | $3.9M | $1.9M | $-296.6K | $-101.8K | $-25.4K | $-19.2K | $102.6K |
| Gross Margin | 63.9% | 54.6% | -23.4% | -115.2% | -2,807.6% | -2,441.1% | 81.7% |
| Operating Expenses | |||||||
| Research & Development | — | — | $93.1K | — | — | — | — |
| SG&A Expense | $2.9M | $770.5K | $567.9K | $302.3K | $122.1K | $184.4K | $188.5K |
| Operating Income | $127.7K | $775.3K | $-1.7M | $-817.3K | $-558.1K | $-774.8K | $-373.7K |
| Operating Margin | 2.1% | 21.8% | -133.1% | -924.8% | -61,741.7% | -98,699.0% | -297.5% |
| Interest Expense | $592.4K | $-290.8K | $-206.6K | $-56.2K | — | — | — |
| Pretax Income | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — |
| Net Income | $-1.2M | $-198.9K | $-1.8M | $-7.4M | $-535.6K | $-809.5K | $-377.4K |
| Net Margin | -19.7% | -5.6% | -145.4% | -8,396.6% | -59,248.6% | -103,126.1% | -300.5% |
| EPS (Basic) | $-0.01 | $0.00 | $-0.04 | $-0.23 | $-0.02 | $-0.04 | $-0.02 |
| EPS (Diluted) | $-0.01 | $0.00 | $-0.04 | $-0.23 | $-0.02 | $-0.04 | $-0.02 |
| Shares Outstanding (Basic) | 176.9M | 52.0M | 32.0M | 31.9M | 30.3M | 19.8M | 19.9M |
| Shares Outstanding (Diluted) | 176.9M | 52.0M | 32.0M | 31.9M | 30.3M | 19.8M | 19.9M |
| Dividends Per Share | — | — | — | — | — | — | — |